Cancer Letters · 2024 · 16 citations · 46 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologyPost-translational ModificationCancer Cell SignalingPost-translational RegulationProtein DegradationProtein Kinase CascadesProtein PhosphorylationBranched-chain Amino AcidsCancer Cell Survival SignalingCross-talk RegulationCross-talk With UbiquitinationE3 Ubiquitin Ligase Substrate RecognitionGlioblastoma Molecular PathwaysRegulation By E3 Ubiquitin LigasesUbiquitin-mediated Pathway Cross-talk
Branched-chain amino acid transferase 1 (BCAT1) is highly expressed in multiple cancers and is associated with poor prognosis, particularly in glioblastoma (GBM). However, the post-translational modification (PTM) mechanism of BCAT1 is unknown. Here, we investigated the cross-talk mechanisms between phosphorylation and ubiquitination modifications in regulating BCAT1 activity and stability. We found that BCAT1 is phosphorylated by branched chain ketoacid dehydrogenase kinase (BCKDK) at S5, S9, and T312, which increases its catalytic and antioxidant activity and stability. STUB1 (STIP1 homology U-box-containing protein 1), the first we found and reported E3 ubiquitin ligase of BCAT1, can also be phosphorylated by BCKDK at the S19 site, which disrupts the interaction with BCAT1 and inhibits its degradation. In addition, we demonstrate through in vivo and in vitro experiments that BCAT1 phosphorylation inhibiting its ubiquitination at multiple sites is associated with GBM proliferation and that inhibition of the BCKDK-BCAT1 axis enhances the sensitivity to temozolomide (TMZ). Overall, we identified novel mechanisms for the regulation of BCAT1 modification and elucidated the importance of the BCKDK-STUB1-BCAT1 axis in GBM progression.
46
Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia
Ayuna Hattori, Makoto Tsunoda, Takaaki Konuma et al. · Nature · 2017 · 403 citations
Medicine, Cancer Biology, Oncology +15